Hospital Costs of Injection Drug Use in Florida

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2020 Jun 22

PMID 32564077

Citations 13

Authors

Austin E Coye

Kasha J Bornstein

Tyler S Bartholomew

Hua Li

Stanley Wong

Naveed Z Janjua

Hansel E Tookes

Joan E St Onge

Affiliations

Soon will be listed here.

Abstract

People who inject drugs (PWID) experience significant injection-related infections (IRIs) at significant healthcare system cost. This study used and validated an algorithm based on the International Classification of Diseases, Tenth Revision, to estimate hospitalized PWID populations, assess the total statewide morbidity for IRIs among PWID, and calculate associated costs of care.

Citing Articles

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients', community organization and healthcare workers' perspectives.

Bedard K, Boisvert I, Rochette M, Racine E, Martel-Laferriere V BMC Infect Dis. 2025; 25(1):221.

PMID: 39953410 PMC: 11829365. DOI: 10.1186/s12879-025-10617-y.

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.

Greenwald M, Wiest K, Haight B, Laffont C, Zhao Y Harm Reduct J. 2023; 20(1):173.

PMID: 38042801 PMC: 10693082. DOI: 10.1186/s12954-023-00906-7.

Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs.

Nolan N, Fracasso Francis S, Marks L, Beekmann S, Polgreen P, Liang S Open Forum Infect Dis. 2023; 10(8):ofad402.

PMID: 37593531 PMC: 10428197. DOI: 10.1093/ofid/ofad402.

Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.

Hervera B, Seo G, Bartholomew T, Chueng T, Suarez E, Forrest D Addict Sci Clin Pract. 2023; 18(1):8.

PMID: 36747268 PMC: 9902242. DOI: 10.1186/s13722-023-00363-4.

Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.

Syros A, Rodriguez M, Rennick A, Dima G, Gibstein A, Parte L Addict Sci Clin Pract. 2022; 17(1):63.

PMID: 36401298 PMC: 9673453. DOI: 10.1186/s13722-022-00346-x.

References

Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S . A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida. PLoS One. 2015; 10(6):e0129360. PMC: 4468183. DOI: 10.1371/journal.pone.0129360. View

Kennedy-Hendricks A, Richey M, McGinty E, Stuart E, Barry C, Webster D . Opioid Overdose Deaths and Florida's Crackdown on Pill Mills. Am J Public Health. 2015; 106(2):291-7. PMC: 4985852. DOI: 10.2105/AJPH.2015.302953. View

Bull-Otterson L, Huang Y, Zhu W, King H, Edlin B, Hoover K . Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017. J Infect Dis. 2020; 222(6):940-947. PMC: 11440361. DOI: 10.1093/infdis/jiaa017. View

Ciccarone D, Unick G, Cohen J, Mars S, Rosenblum D . Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions. Drug Alcohol Depend. 2016; 163:126-33. PMC: 4881875. DOI: 10.1016/j.drugalcdep.2016.04.009. View

Meisner J, Anesi J, Chen X, Grande D . Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic. Clin Infect Dis. 2019; 71(7):1664-1670. PMC: 8241215. DOI: 10.1093/cid/ciz1038. View

Assoumou S, Wang J, Nolen S, Yazdi G, Mayer K, Puro J . HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020; 35(5):1477-1483. PMC: 7210368. DOI: 10.1007/s11606-020-05701-9. View

Stearns C, Bakamjian A, Sattar S, Weintraub M . Discharges Against Medical Advice at a County Hospital: Provider Perceptions and Practice. J Hosp Med. 2017; 12(1):11-17. DOI: 10.1002/jhm.2672. View

Hope V, Kimber J, Vickerman P, Hickman M, Ncube F . Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008; 8:120. PMC: 2600824. DOI: 10.1186/1471-2334-8-120. View

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P . Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017; 5(12):e1192-e1207. PMC: 5683738. DOI: 10.1016/S2214-109X(17)30375-3. View

10.

Hood J, Behrends C, Irwin A, Schackman B, Chan D, Hartfield K . The projected costs and benefits of a supervised injection facility in Seattle, WA, USA. Int J Drug Policy. 2019; 67:9-18. DOI: 10.1016/j.drugpo.2018.12.015. View

11.

Fleischauer A, Ruhl L, Rhea S, Barnes E . Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence - North Carolina, 2010-2015. MMWR Morb Mortal Wkly Rep. 2017; 66(22):569-573. PMC: 5720243. DOI: 10.15585/mmwr.mm6622a1. View

12.

Epstein R, Wang J, Hagan L, Mayer K, Puro J, Linas B . Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019; 322(22):2245-2248. PMC: 7081751. DOI: 10.1001/jama.2019.16196. View

13.

Janjua N, Islam N, Kuo M, Yu A, Wong S, Butt Z . Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. Int J Drug Policy. 2018; 55:31-39. DOI: 10.1016/j.drugpo.2018.02.001. View

14.

Wurcel A, Anderson J, Chui K, Skinner S, Knox T, Snydman D . Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs. Open Forum Infect Dis. 2016; 3(3):ofw157. PMC: 5084714. DOI: 10.1093/ofid/ofw157. View

15.

Takahashi T, Maciejewski M, Bradley K . US hospitalizations and costs for illicit drug users with soft tissue infections. J Behav Health Serv Res. 2009; 37(4):508-18. DOI: 10.1007/s11414-009-9177-z. View